Itch

Lancet

Volumn 361, Issue 9358, 2003, Pages 690-694

  Yosipovitch, Gil ^a   Greaves, Malcolm W ^b   Schmelz, Martin ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4;

HUMAN; MEDICAL RESEARCH; NERVE TRACT; NEUROPATHY; NEUROPHYSIOLOGY; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; REVIEW; SCRATCHING; SKIN SENSATION;

EID: 0037460681     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12570-6     Document Type: Review

References (76)

1. Greaves M.W., Wall P.D. Pathophysiology of itching. Lancet. 348:1996;938-940.
2. McMahon S.B., Koltzenburg M. Itching for an explanation. Trends Neurosci. 15:1992;497-501.
3. Bickford R.G.L. Experiments relating to itch sensation, its peripheral mechanism and central pathways. Clin Sci. 3:1938;377-386.
4. Twycross R., Greaves M.W., Handwerker H., et al. Itch: scratching more than the surface. QJM. 96:2003;7-26.
5. Bernhard J.D. Neurogenic pruritus and strange sensations. Bernhard J.D. Itch Mechanisms and Management of Pruritus. 1994;185-202 McGraw-Hill, New York.
6. Krause L., Shuster S. Mechanism of action of antipruritic drugs. BMJ. 287:1983;1199-1200.
7. Schmelz M., Schmidt R., Bickel A., et al. Specific C receptors for itch in human skin. J Neurosci. 17:1997;8003-8008.
8. Andrew D., Craig A.D. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 4:2001;72-77.
9. Schmelz M. A neural pathway for itch. Nat Neurosci. 4:2001;9-10.
10. Hsieh J.C., Hagermark O., Stahle-Backdahl M., et al. Urge to scratch represented in the human cerebral cortex. J Neurophysiol. 72:1994;3004-3008.
11. Darsow U., Drzezega A., Frisch M., et al. Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol. 115:2000;1029-1033.
12. Drzezga A., Darsow U., Treede R.D., et al. Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain. 92:2001;295-305.
13. McGlone F., Rukwied R., Hitchcock D., et al. Functional MRI response to histamine iontophoresis. Yosipovitch G. Abstracts International Workshop for The Study of Itch. 2001;22-23 National Skin Center Singapore, Singapore.
14. Peyron R., Laurent B., Garcia-Larrera L. Functional imaging of brain responses to pain: a review and meta-analysis (2000). Neurophysiol Clin. 30:2000;263-288.
15. Greaves M.W., Wall P.D. Pathophysiology and clinical aspects of pruritus. Freedberg I.M. Dermatology in General Medicine. 5th edn:1998;487-494 McGraw Hill, New York.
16. Nilsson H.J., Levinsson A., Schouenborg J. Cutaneous field stimulation (CFS): a new powerful method to combat itch. Pain. 71:1997;49-55.
17. Kirchner A., Stefan H., Schmelz M., et al. Influence of vagus nerve stimulation on histamine induced itching. Neurology. 59:2002;108-112.
18. Nilsson HJ. Itch and pain inhibitory mechanisms in human - evidence for a differential control of nociceptive senses. Dissertation, University of Lund, 1999.
19. Steinhoff M., Vergnolle N., Young S.H., et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med. 6:2000;151-158.
20. Schmelz M., Zeck S., Raithel M., Rukwied R. Mast cell tryptase in dermal neurogenic inflammation. Clin Exp Allergy. 29:1999;695-702.
21. Weidner C., Klede M., Rukwied R., et al. Acute effects of substance P and calcitonin gene-related peptide in human skin-a microdialysis study. J Invest Dermatol. 115:2000;1015-1020.
22. Suzuki R., Furuno T., McKay D.M., et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol. 163:1999;2410-2415.
23. Cocchiara R., Lampiasi N., Albeggiani G., et al. Mast cell production of TNF-alpha induced by substance P evidence for a modulatory role of substance P-antagonists. J Neuroimmunol. 101:1999;128-136.
24. Jancso N., Jancso-Gabor A., Solzcsanyi J. Direct evidence of neurogenic inflammation, and its prevention by denervation and by treatment with capsaicin. Br J Pharmacol. 31:1967;138-151.
25. Lynn B. Capsaicin: actions on C fibre afferents that may be involved in itch. Skin Pharmacol. 5:1992;9-13.
26. Kuraishi Y., Nagasawa T., Hayashi K., Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol. 275:1995;229-233.
27. Jinks S.L., Carstens E. Responses of superficial dorsal horn neurons to intradermal serotonin and other irritants: comparison with scratching behavior. J Neurophysiol. 87:2002;1280-1289.
28. Chan L.S., Robinson N., Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol. 117:2001;977-983.
29. Yagi R., Nagai H., Iigo Y., et al. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol. 168:2002;2020-2027.
30. Pauli-Magnus C., Mikus G., Alscher D.M., et al. Naltrexone does not relieve uremic pruritus: results of randomized, placebo controlled crossover-study. J Am Soc Nephrol. 11:2000;514-519.
31. Murphy M., Carmichael A.J. Renal itch. Clin Exp Dermatol. 25:2000;103-106.
32. Schwartz I.F., Iaina A. Uraemic pruritus. Nephrol Dial Transplant. 14:1999;834-839.
33. Peer G., Kivity S., Agami O., et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet. 348:1996;1552-1554.
34. Togashi Y., Umeuchi H., Okano K., et al. Antipruritic activity of the [kappa]-opioid receptor agonist, TRK-820. Eur J Pharmacol. 435:2002;259-264.
35. Kamei J., Nagase H. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol. 418:2001;141-145.
36. Kumagai H., Sasamura H., Hayashi M., et al. Prospects for a novel opioid kappa receptor agonist TRK-820 in uremic pruritus. Yosipovitch G. International Workshop for the Study of Itch. 2001;59 National Skin Center, Singapore, Singapore.
37. Chia S.C., Bergasa N.V., Kleiner D.E., et al. Pruritus as a presenting symptom of chronic hepatitis C. Dig Dis Sci. 43:1998;2177-2183.
38. Jones E.A., Bergasa N.V. The pruritus of cholestasis. Hepatology. 29:1999;1003-1006.
39. Grant A.D., De Cock K.M. HIV infection and AIDS in the developing world. BMJ. 322:2001;1475-1479.
40. Rodwell G.E., Berger T.G. Pruritus and cutaneous inflammatory conditions in HIV disease. Clin Dermatol. 18:2000;479-484.
41. Oh S.B., Tran P.B., Gillard S.E., et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 21:2001;5027-5035.
42. Herzberg U., Sagen J. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J Neuroimmunol. 116:2001;29-39.
43. Oaklander A.L., Cohen S.P., Raju S.V.Y. Intractable postherpetic itch and cutaneous deafferenation after facial shingles. Pain. 96:2002;9-12.
44. Yamamoto M., Yabuki S., Hayabara T. Paroxysmal itching in multiple sclerosis: a report of three cases. J Neurol Neurosurg Psychiatry. 44:1981;19-22.
45. Sandyk R. Paroxysmal itching in multiple sclerosis during treatment with external magnetic fields. Int J Neurosci. 75:1994;65-71.
46. Heyer G., Ulmer F.J., Schmitz J., Handwerker H.O. Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls. Acta Derm Venereol. 75:1995;348-352.
47. Rukwied R., Lischetzki G., McGlone F., et al. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol. 142:2000;1114-1120.
48. Monroe E.W. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. J Am Acad Dermatol. 21:1989;135-136.
49. Monti J.M., Vignale R., Monti D. Sleep and night-time pruritus in children with atopic dermatitis. Sleep. 12:1989;309-314.
50. Lear J.T., English J.S., Jones P., Smith A.J. Retrospective review of the role of azathioprine in severe atopic dermatitis. J Am Acad Dermatol. 35:1996;642-643.
51. Sowden J.M., Berth-Jones, Ross J.S., et al. Double blind controlled cross-over study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet. 338:1991;137-140.
52. Ruzicka T., Bieber T., Schopf E., et al. A short term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med. 337:1997;816-821.
53. Krueger G., Koo J., Lebwohl M., et al. The impact of psoriasis on quality of life: results of a National Psoriasis Foundation patient-membership survey. Arch Dermatol ; 137. 2001:1998;280-284.
54. Yosipovitch G., Goon A., Wee J., et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 143:2000;969-973.
55. Naukkarinen A., Nickoloff B.J., Farber E.M. Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol. 92:1989;126-129.
56. Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol. 10:2000;85-90.
57. Darsow U., Scharein E., Simon D., et al. New aspects of itch pathophysiology: component analysis of atopic itch using the 'Eppendorf Itch Questionnaire'. Int Arch Allergy Immunol. 124:2001;326-331.
58. Yosipovitch G., Zucker I., Boner G., et al. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol. 81:2001;108-111.
59. Ebata T., Aizawa H., Kamide R., Niimura M. The characteristics of nocturnal scratching in adults with atopic dermatitis. Br J Dermatol. 141:1999;82-86.
60. Talbot T.L., Schmitt J.M., Bergasa N.V., et al. Application of piezo film technology for the quantitative assessment of pruritus. Biomed Instrum Technol. 25:1991;400-403.
61. Endo K., Sumitsuji H., Fukuzumi T., et al. Evaluation of scratch movements by a new scratch-monitor to analyze nocturnal itching in atopic dermatitis. Acta Derm Venereol. 77:1997;432-435.
62. Ebata T., Iwasaki S., Kamide R., Niimura M. Use of a wrist activity monitor for the measurement of nocturnal scratching in patients with atopic dermatitis. Br J Dermatol. 144:2001;305-309.
63. Wahlgren C.F. Measurement of itch. Semin Dermatol. 14:1995;277-284.
64. Folster-Holst R., Brasch J. Effect of topically applied capsaicin on pruritus in patients with atopic dermatitis. J Dermatol Treatment. 7:1996;13-15.
65. Yosipovitch G., Maibach H.I., Rowbotham M.C. Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia. Acta Derm Venereol. 79:1999;118-121.
66. Drake L.A., Fallon J.D., Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol. 31:1994;613-616.
67. Greaves M.W., McDonald-Gibson W. Itch: role of prostaglandins. BMJ. 3:1973;608-609.
68. Daly B.M., Shuster S. Effect of aspirin on pruritus. BMJ. 293:1986;907.
69. Yosipovitch G., Ademola J., Ping L., et al. Topically applied aspirin rapidly decreases histamine induced itch. Acta Derm Venereol. 77:1997;46-48.
70. Yosipovitch G., Sugeng M.W., Chan Y.H., et al. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol. 45:2001;910-913.
71. Miller M.J., Vergnolle N., McKnight W., et al. Inhibition of neurogenic inflammation by the Amazonian herbal medicine sangre de grado. J Invest Dermatol. 117:2001;725-730.
72. Bergasa N.V., Talbot T.L., Alling D.W., et al. A controlled trial of naloxone infusions for the pruritus of cholestasis. Gastroenterology. 102:1992;544-549.
73. Bergasa N.V., Alling D.W., Talbot T.L., et al. Oral nalmefene therapy reduces scratching activity due to pruritus of cholestasis: a controlled study. J Am Acad Dermatol. 41:1999;431-434.
74. Metze D., Reimann S., Beissert S., Luger T. Efficacy and safety of naltrexone, and oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol. 41:1999;533-539.
75. Fishman S.M., Caneris O.A., Stojanovic M.P., Borsook D. Intravenous lidocaine for treatment-resistant pruritus. Am J Med. 102:1997;584-585.
76. Bueller H.A., Bernhard J.D., Dubroff L.M. Gabapentin treatment for brachioradial pruritus. J Eur Acad Dermatol Venereol. 13:1999;227-228.